Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Initiation and continuation of oral anticoagulant prescriptions for stroke prevention in non-valvular atrial fibrillation: A cohort study in primary care in France

(2018) Shuk-Li Collings et al.   Archives of Cardiovascular Diseases

Use of Non-Vitamin K Antagonist Oral Anticoagulants 2008-2016: A Danish Nationwide Cohort Study

(2018) Simone Bonde Haastrup et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States

(2018) Konstantinos C. Siontis et al.   CIRCULATION

Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands

(2018) Maartje S. Jacobs et al.   CURRENT MEDICAL RESEARCH AND OPINION

Impact of medication adherence on risk of ischemic stroke, major bleeding and deep vein thrombosis in atrial fibrillation patients using novel oral anticoagulants

(2018) Chinmay G. Deshpande et al.   CURRENT MEDICAL RESEARCH AND OPINION

Characteristics of Apixaban-Treated Patients, Evaluation of the Dose Prescribed, and the Persistence of Treatment: A Cohort Study in Catalonia

(2018) Ainhoa Gomez-Lumbreras et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban

(2018) Gregory Y. H. Lip et al.   PLoS One

Dabigatran persistence and adherence in New Zealand: a nationwide retrospective observational study

(2018) Paul Harper et al.   BMJ Open

Factors influencing dabigatran or warfarin medication persistence in patients with nonvalvular atrial fibrillation

(2018) Srinivas Annavarapu et al.   Journal of Comparative Effectiveness Research

Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation

(2017) Cynthia A Jackevicius et al.   HEART

Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation

(2017) Miney Paquette et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study

(2017) Antonios Douros et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study

(2017) Géric Maura et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies

(2017) Tanja Mueller et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation

(2017) Beenish S. Manzoor et al.   PHARMACOTHERAPY

Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases

(2017) Géric Maura et al.   PHARMACOTHERAPY

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients

(2017) Morten Lamberts et al.   Journal of the American Heart Association

Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation

(2017) Colleen A. McHorney et al.   Journal of Managed Care & Specialty Pharmacy

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data

(2017) Joshua D. Brown et al.   Journal of Managed Care & Specialty Pharmacy

Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany

(2017) Shuk-Li Collings et al.   PLoS One

Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation

(2016) Maja Hellfritzsch et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Health Care Resource Utilization, Costs, and Persistence in Patients Newly Diagnosed as Having Nonvalvular Atrial Fibrillation and Newly Treated With Dabigatran versus Warfarin in the United States

(2016) Tim Bancroft et al.   CLINICAL THERAPEUTICS

Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation

(2016) Colleen A. McHorney et al.   CLINICAL THERAPEUTICS

Improved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experience

(2016) Leon A. Simons et al.   CURRENT MEDICAL RESEARCH AND OPINION

Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation

(2016) Jan Beyer-Westendorf et al.   EUROPACE

Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States

(2016) Craig I. Coleman et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke

(2016) Mark J. Alberts et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients

(2016) Anuj Shah et al.   STROKE

Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC

(2016) Anja Katholing et al.   THROMBOSIS AND HAEMOSTASIS

Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia

(2016) Semira Abdi Beshir et al.   International Journal of Clinical Pharmacy

Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care

(2016) Michelle E Johnson et al.   BMJ Open

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

(2016) Xiaoxi Yao et al.   Journal of the American Heart Association

Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States

(2016) Craig I. Coleman et al.   PLoS One

Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation

(2015) Tomas Forslund et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Site-Level Variation in and Practices Associated With Dabigatran Adherence

(2015) Supriya Shore et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study

(2015) A. Gorst-Rasmussen et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review

(2015) D.M. Adcock et al.   THROMBOSIS RESEARCH

Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation

(2015) Meijia Zhou et al.   Journal of Managed Care & Specialty Pharmacy

Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration

(2014) Supriya Shore et al.   AMERICAN HEART JOURNAL

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients

(2014) François Laliberté et al.   CURRENT MEDICAL RESEARCH AND OPINION

Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation

(2014) Winnie W. Nelson et al.   CURRENT MEDICAL RESEARCH AND OPINION

Continuation of Dabigatran Therapy in “Real-World” Practice in Hong Kong

(2014) Mei Han Ho et al.   PLoS One

Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population

(2013) Susan Colilla et al.   AMERICAN JOURNAL OF CARDIOLOGY

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin

(2013) Martin Zalesak et al.  

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of dosing frequency on chronic cardiovascular disease medication adherence

(2012) Craig I. Coleman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictive Validity of a Medication Adherence Measure in an Outpatient Setting

(2008) Donald E. Morisky et al.   Journal of Clinical Hypertension